BRPAU - (Big Rock Partners Acquisition Corp.)

BRPAUのニュース

   NeuroRx completes merger with SPAC, starts trading on Nasdaq  2021/05/25 11:58:58 Drug Delivery Business
NeuroRx announced today that it commenced trading on the Nasdaq market following its merger with Big Rock Partners Acquisition Corp. The combined business entity will be known as NRx Pharmaceuticals and will trade on the Nasdaq market under the NRXP ticker, according to a news release. Radnor, Pa.-based NRx develops Zyesami, a synthetic form of [] The post NeuroRx completes merger with SPAC, starts trading on Nasdaq appeared first on Drug Delivery Business .
   NRx Pharmaceuticals, Inc. Commences Trading on Nasdaq as NRXP, Following Merger Between NeuroRx, Inc. and Big Rock Partners Acquisition Corp (Nasdaq:BRPA)  2021/05/25 00:00:00 BioSpace
Newly formed publicly traded company NRx Pharmaceuticals, Inc. (NRx) to be traded under the ticker symbol "NRXP" on the Nasdaq Global Market
   MMAC leads financial gainers, SRAC and RELI among losers  2021/05/24 16:59:25 Seeking Alpha
   Big Rock Partners Acquisition Corp. Announces Effectiveness of Registration Statement; Confirms Annual Meeting Date of May 24, 2021 to Approve Proposed Merger with NeuroRx  2021/05/21 22:44:00 FinanzNachrichten
Big Rock Partners Recommends All Stockholders Vote "FOR" ALL Proposals at Annual Meeting NEW YORK, NY / ACCESSWIRE / May 21, 2021 / Big Rock Partners Acquisition Corp. ("Big Rock" or "BRPA") (Nasda
   LendingClub leads financial gainers, LM Funding America and Reliance Global among losers  2021/05/21 17:12:39 Seeking Alpha
   NeuroRx completes merger with SPAC, starts trading on Nasdaq  2021/05/25 11:58:58 Drug Delivery Business
NeuroRx announced today that it commenced trading on the Nasdaq market following its merger with Big Rock Partners Acquisition Corp. The combined business entity will be known as NRx Pharmaceuticals and will trade on the Nasdaq market under the NRXP ticker, according to a news release. Radnor, Pa.-based NRx develops Zyesami, a synthetic form of [] The post NeuroRx completes merger with SPAC, starts trading on Nasdaq appeared first on Drug Delivery Business .
   NRx Pharmaceuticals, Inc. Commences Trading on Nasdaq as NRXP, Following Merger Between NeuroRx, Inc. and Big Rock Partners Acquisition Corp (Nasdaq:BRPA)  2021/05/25 00:00:00 BioSpace
Newly formed publicly traded company NRx Pharmaceuticals, Inc. (NRx) to be traded under the ticker symbol "NRXP" on the Nasdaq Global Market
   MMAC leads financial gainers, SRAC and RELI among losers  2021/05/24 16:59:25 Seeking Alpha
   Big Rock Partners Acquisition Corp. Announces Effectiveness of Registration Statement; Confirms Annual Meeting Date of May 24, 2021 to Approve Proposed Merger with NeuroRx  2021/05/21 22:44:00 FinanzNachrichten
Big Rock Partners Recommends All Stockholders Vote "FOR" ALL Proposals at Annual Meeting NEW YORK, NY / ACCESSWIRE / May 21, 2021 / Big Rock Partners Acquisition Corp. ("Big Rock" or "BRPA") (Nasda
   LendingClub leads financial gainers, LM Funding America and Reliance Global among losers  2021/05/21 17:12:39 Seeking Alpha
   63 Biggest Movers From Friday  2021/03/29 09:16:11 Benzinga
Gainers Elite Education Group International Ltd. (NASDAQ: EEIQ ) shares climbed 287.5% to close at $15.50 on Friday. The company, on Thursday, priced its 750,000 unit offering at $8 per unit. Wah Fu Education Group Limited (NASDAQ: WAFU ) shares gained 167.1% to close at $12.66. Chinese education stocks were trading sharply higher Friday morning, potentially following the Thursday IPO of a peer in the space, Elite Education. Design Therapeutics, Inc. (NASDAQ: DSGN ) shares jumped 107.5% to close at $41.49 after the company priced its IPO at $20 per share. Ikena Oncology, Inc. (NASDAQ: IKNA ) surged 100% to close at $32.00 after the company priced its IPO at $16 per share. Edgewise Therapeutics, Inc. (NASDAQ: EWTX ) gained 87.5% to close at $30.00 after pricing its IPO at $16 per share. ThredUp Inc. (NASDAQ: TDUP ) rose 42.9% to close at $20.00 as the company priced its IPO at $14 a share. Big Rock Partners Acquisition Corp. (NASDAQ: BRPA ) gained 36.4% to close at $35.89 after the company announced the completion of top line data analysis in its Phase 2b/3 clinical trial of ZYESAMI for the treatment of COVID-19 respiration failure.
   Bulawayo residents accuse Chamisa of hypocrisy  2020/03/19 06:41:09 Bulawayo24 News
The Bulawayo Progressive Residents Association (BRPA) has accused MDC leader Nelson Chamisa of "hypocrisy" by meddling in council affairs after the party locked out mayor Solomon Mguni and five counci…

calendar